Litcius/Paper detail

D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial

Maurizio Degiuli, Rossella Reddavid, Mariano Tomatis, Antonio Ponti, Mario Morino, Mitsuru Sasako, Fabrizio Rebecchi, M Garino, Luca Viganò, Donatella Scaglione, L. Locatelli, Paolo Mello Teggia

2021European Journal of Cancer65 citationsDOI

Topics & Concepts

MedicineCancerRandomized controlled trialPopulationGastrectomyLymphadenectomySurgeryQuality of life (healthcare)Lymph nodeDissection (medical)Internal medicineNursingEnvironmental healthGastric Cancer Management and OutcomesEsophageal Cancer Research and TreatmentEsophageal and GI Pathology
D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial | Litcius